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Numerous experiments on the stimulatory requirements for antigen-sensitized
Tcells have yielded valuable information on the role ofantigen processing in gener-
ating epitopes that are recognized by T cells in association with MHC molecules
(1-6). These studies ofimmune recognitionhave used chronically activated ortrans-
formed T cells. Stimulation ofthe MLR is a distinctive system, because it permits
an analysis ofthe activation requirements forsmallrestingT cells and freshly sensi-
tized lymphoblasts derived therefrom. Previously, it has been found that allogeneic
MHC molecules on stimulator leukocytes are not sufficient to induce proliferation
or lymphokine production from resting T cells. In particular, dendritic cells, small
B cells, andmacrophages all express MHC products, and can stimulatealloreactive,
sensitized T lymphoblasts; yet, dendritic cells are at least 1-2 logs more active in
stimulating resting T cells in the MLR (7, 8). Similar findings have been made for
allograftresponsesin situ (9) andforTdependent antibody responsesinculture (10, 11).
The finding that small B cells are inefficient at stimulating resting T cells is of
interest, since T cell help for antibody responses is classically delivered to B cells
in an MHC-restricted fashion (12, 13). It follows that antigen-specificTand B cells
should directlyinteract during the antibody response. It has previously been shown
that preactivation ofeither the responderT cells, with allogeneic dendritic cells (7,
8), or the stimulator B cells, with LPS (14), leads to significant levels of antigen-
specific TB interactions. Also, there is evidence that antigen-specific B cells bind
and process antigen via surface Ig to yield peptides that are presented to T cells
in association with class II molecules on the B cell (15). We wondered, therefore,
whether B cells thathave previously encountered antigen andbeen activated through
their surface Ig might be better than resting B cells as stimulators of primary T
cells. We chose to study B cells that have been activated with anti-Ig coupled to
Sepharose as a model for antigen-specific activation of B cells (16).
We describe here the properties ofthese anti-Ig activated B cells (anti-Ig blasts)
in the primary MLR, comparing the blasts to small B cells and spleen dendritic
cells. We find that allogeneic anti-Ig blasts can directly activate resting CD4' T
cells, and that this process shares many properties in common with dendritic cells.
However, there are some important differences between these two types ofAPCs,
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including their efficiency at binding alloreactive T cells and the molecular interac-
tions required for this binding.
Mice
Materials and Methods
Mice of either sex were used between 7 and 10 wk old. [BALB/c x DBA/2]F, [C x D2
F, ; H-2d, Mls-d], [C57BL/6 x DBA/2]F, [B6xD2 ; H-2bxd, Mlsbxd], and C57BL/6 congenic
for H-2 k [B6.H-2k ; Mlsb] were purchased from the Trudeau Institute, Saranac Lake, NY,
CBA/J [H-2
k, Mlsd] were purchased from The Jackson Laboratories, Bar Harbor, ME; and
C57BL/6 [B6; H-26 , Mlsb] were purchased from Charles River Breeding Laboratories, Wil-
mington, MA.
Monoclonal Antibodies
A panel of mAbs, summarized elsewhere (17), were used in the form of hybridoma culture
supernatants. For blocking experiments the mAbs were used at a final concentration of 25 %
(vol/vol); for complement depletion assays, optimal dilutions of mAbs were predetermined
in microcytotoxicity assays; and for FAGS analysis, the hybridoma supernatants were typi-
cally used at a 1 :5 dilution.
Culture Medium
Culture medium in all cases was RPMI 1640 containing 10% heat-inactivated FCS (Hy-
Clone Laboratories, Logan, UT or Hazelton Biologics, Inc., Lenexa, KS), 50 gM 2-ME,
glutamine, and antibiotics.
Cells
Dendritic Cells.
￿
Dendritic cells were prepared from spleen low density adherent cells ob-
tained by flotation on dense BSA gradients (density = 1.08) and adherence to tissue culture
dishes (Falcon Labware, Lincoln Park, NJ). Nonadherent cells were vigorously dislodged
by pipetting over the monolayer at 2 h. The adherent cells were cultured overnight, where-
upon the dendritic cells became nonadherent. The overnight released cells were depleted of
contaminating Fc receptor-bearing B cells and macrophages by rosetting with SRBC coated
with a mouse anti-SRBC antiserum (18). Alternatively, macrophages were depleted by read-
hering the cells to tissue culture plastic.
Sßlenic B cells.
￿
Single cell suspensions, depleted of RBC by NH4C1 lysis, were passed over
columns of Sephadex G-10 (Pharmacia Fine Chemicals, Piscataway, NJ) to remove macro-
phage and dendritic cells. T cells were then depleted by incubating the cells with anti-Lyt-1 .1
(C3PC), antiThy-1 .2 (HO-13.4, ATCC TIB 99), and anti-Lyt-2 (3.155, ATCC TIB 211) hy-
bridoma supernatants on ice, then adding rabbit complement (Pel Freeze Biologicals, R6gers,
AR) and incubating for 60 min at 37°C. We refer to these cells as small B cells, but these
populations contain a small percentage ofin vivo-activated, low density B cells (see Results).
B Blasts.
￿
B cells were cultured with 5 wg/ml affinity-purified goat anti-mouse Ig (Jackson
ImmunoResearch, West Grove, PA) coupled to Sepharose (1 mg antibody per milliliter packed
Sepharose; Pharmacia Fine Chemicals) at 2 x 106 cells/ml in upright 25-cm T flasks for 48 h.
The Sepharose was removed by centrifugation on Ficoll-Paque (Pharmacia Fine Chemicals),
and the activated B lymphoblasts were further enriched on discontinuous gradients ofPercoll
(Pharmacia Fine Chemicals) (19). We refer to such cells as anti-Ig blasts. B cells cultured
for 48 h with 20 wg/ml LPS (Salmonella tyßhosa; Difco Laboratories, Inc., Detroit, MI) and
purified as described for anti-Ig blasts yielded a population referred to as LPS blasts.
T Cells.
￿
Single cell suspensions from either mesenteric lymph node or mesenteric lymph
node and spleen were depleted of RBC and then passed over nylon wool columns (Fenwal
Laboratories, Deerfield, IL) to remove most dendritic cells, macrophages, and B cells. CD4'
T cells were further enriched by incubating the nylon wool nonadherent cells with anti-la
(B21-2, ATCC TIB229, anti-I-Ab.d; or 10-2.16, ATCC TIB 93, anti-I-A') and anti-Lyt-2
(3.155, ATCC TIB 213 and HO-2.2, ATCC TIB 150) plus rabbit complement, as described
(7). In most experiments viable T cells were enriched by centrifugation through premixed
solutions of 45% Percoll, 45% HBSS, and 10% FCS.Mixed Leukocyte Reaction
Primary MLR.
￿
T cells (3-5 x 105) were cultured with graded doses of stimulators in 96-
well flat-bottomedplates (microwells) in a totalvolume of 200 wl for the indicated times. Un-
less otherwise indicated, anti-Ig blasts and dendritic cells were treated with 3,000 rad and
small B cells with 900 rad irradiation from a'37Cs source before their addition to the cul-
tures. Cultures were pulsed with 1 WCi/well [3H]TdR (6.7 mCi/mmole; ICN Radiochem-
icals, Irvine, CA)] for the last 8-16 h of the culture.
SecondaryMLR.
￿
Alloreactive T lymphoblasts were generated by culturing 5 x 106 T cells
with 1-2% allogeneic dendritic cells in 24-well flat-bottomed plates (macrowells) (7). At 48
h, dendriticTcell clusters were isolated by velocity sedimentation on Percoll gradients and
then recultured at 3-5 x 105 cells/macrowell for48 h more. Released lymphoblasts were har-
vested free of clusters by a second velocity sedimentation (7). Contaminating dendritic cells
and CD8` T cells were removed with mAb (anti-Ia, anti-Lyt-2) plus complement. Alloreac-
tive T blasts were restimulated at 3 x 104 blasts/microwell with graded doses of stimulators
for an additional 24 h. Cultures were pulsed with [3H]TdR for the last 8 h.
Lymphokine Bioassays
MLR supernatants were removed from microwells before pulsing (N80 hof primary MLR)
and assayed for IL-2, IL-4, and a B cell growth factor (BCGF).'
Interleukin 2.
￿
IL-2 wasdetected by its abilityto maintain the growth of CTLL cellsseeded
at 5 x 103 cells per well in a final volume of 100 pl. Human rIL-2 was provided by Dr. Seth
Rudnick (Biogen, Cambridge, MA) and served as a positive control. In a more extensive
series oflymphokine studies (20) we reported that 40-60'7o ofthe CTLL proliferation main-
tained by primary MLR supernatants was inhibitable by anti-IL-2 mAb S4B6, while the
remainder of the supernatant activity was not inhibitable by anti-IL-4 mAb 11B11.
Interleukin 4.
￿
IL-4 wasdetected by the costimulation assay in which IL-4 and anti-Igto-
gether induce [3H]TdR incorporation in high density or unfractionated murine B cells as
described (20). As previously reported, this response is completely inhibited by 2-10 wg/ml
11B11 anti-IL-4 mAb (provided by Dr. E. S. Vitetta, Dallas, TX) (20). Murine rIL-4 was
purified on an 11BIl affinity column from the conditioned medium of an IL-4 transfected
HeLa cell line (generously provided by Dr. T. Honjo, Kyoto University, Kyoto, Japan) and
served as a positive control.
BCGF.
￿
Anti-Ig-activated B lymphoblasts proliferate in response to aT cell-derived lym-
phokine(s) distinct from IL-2 or IL-4. We refer to this activity as B cell growth factor or
BCGF (19).
APC-T Cell Binding during the MLR
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During an MLR, dendritic cellsand alloreactive Tcells cluster(7). To measurethe clustering
activity of anti-Ig blasts and to compare them with dendritic cells, these stimulators were
prelabeled with a nontoxic, nontransferable, fluorescent carbocyanine dye (diI; Molecular
Probes, Eugene, OR) at 3 ltg/ml for60 min at 37°C, and then washed twice before use (21).
The clusters were harvestedby velocity sedimentation andthe frequency of diI-labeled cells,
as well as total cells, in the cluster was enumerated.
FACS Analysis
Cell suspensions (105-106 cells per sample) were stained on ice with optimal dilutions of
rat mAbs. The cells were then washed three times with PBS containing 1% BSA and 0.02%
NaN3, stained with FITC-conjugated mouse anti-rat Ig (Boebringer Mannheim Biochem-
icals, Indianapolis, IN), washed, fixed in 3.7% formaldehyde, and analyzed on a FACScan
(Becton Dickinson & Co., Mountain View, CA). Dead cells were gated out based on light
scatter and 5,000-10,000 events were analyzed per sample.
Results
Purity andPhenotype ofDendritic andB Cell Populations.
￿
B cells, anti-Ig blasts, and
dendritic cells were prepared from the spleens of age- and sex-matched mice. Cell
' Abbreviation used in this paper: BCGF, B cell growth factor.242
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size (forward light scatter) and purity were monitored by flow cytometry. The den-
dritic cells had greater forward scatter than the B cells, but were roughly equal in
mean scatterto theanti-Igblasts (Fig. 1, left). The anti-Ig blasts andDC were equally
rich in class II MHC products, having 5-10 times more I-A and I-E than small B
cells (Fig. 1, middle). However, the phenotype ofdendritic cells and B cell popula-
tions was otherwise distinct (middle and right). Small and activated B cells expressed
Fc receptors(mAb 2.4G2), theB220 antigen(mAb RA 3-3A1), andtheJlld antigen
(mAbJ11d), whereas purified dendritic cell populations reacted with none ofthese
mAbs. Dendritic cells stained withthe 33D1 mAb, while the B cell and anti-Ig blast
preparations were negative.
Relatiue Stimulatory Actiaity ofDendritic Cells andAnti-Ig Blasts in the MLR.
￿
Small
splenic B cells were weak stimulators ofthe primary MLR, but anti-Ig blasts were
active (Fig. 2 A). In our initial experiments, the anti-Ig blasts were 3-10 times less
active than dendritic cells in the primary MLR, and equal or more active in the
secondary MLR, on a per cell basis (Fig. 2, A .. and B). Small B cells, in contrast,
were poor stimulators in the primary MLR but were only 10 times less active than
dendritic cells and anti-Ig blasts in the secondaryMLR. Fractionation ofthese fresh
B cells on Percoll discontinuous gradients produced a population of high density
B lymphocytes (19), which were totally inactive in the primary MLR but still re-
stimulated T blasts in the secondary MLR (data not shown), suggesting that a few
activated B cellsin the bulk population give rise tothe responses seen at high stimu-
lator doses. Stimulator cells of the wrong MHC haplotype were nonfunctional in
restimulatingthe alloreactive blasts (Fig. 2 B)demonstratingthe antigen specificity
of the secondary MLR.
The weak ability ofsmall B cells to stimulate a primary MLR suggested that the
contaminationofthese preparations withmature dendriticcells, which are vigorous
primary MLR stimulators, must be very low. However, in the 48-h anti-Ig activa-
tion of the B cells it was possible that relatively immature dendritic cells could ma-
ture and contribute tothe primaryMLR stimulation. To establishpurity ofthe stimu-
lators beyond the FRCS studies ofFig. 1, we treated the stimulator populations with
cell-specific mAbs and complement before use. The two mAbsusedwere 33D1, specific
forthe majorityofdendritic cells in spleen (22), and RA3-3A1, specific for theB220
molecule on B cells (23). Depletion with 33Dl abrogated the stimulatory activity
ofdendritic cellsbutnot anti-Igblasts, while depletion with anti-B220onlydepleted
the function of anti-Ig blasts (Fig. 3).
Role ofMis Products in the Anti-Ig Blast Stimulation ofthe MLR.
￿
In the course of
our studies, several strain combinations, involving full MHC mismatches, with or
without minorhistocompatibility differences, were evaluated. In all cases, dendritic
cells were very active as stimulators, but the activity of anti-Ig blasts varied in a
strain-dependent fashion (data to be shown in Fig. 7, below). For example, CxD2
anti-Ig blasts were nearly as potent as CxD2 dendritic cells in stimulating B6.H-2k
T cells, while B6.H-2k anti-Ig blasts were 30-foldless potent than B6.H-2k dendritic
cells at stimulating CxD2 T cells. Since CxD2 but not B6 mice carry strong Mls
antigens (24), we suspected that the strong MLR stimulation by anti-Ig blasts in
some strain combinations was due to the preferential expression of Mls antigens
bythose anti-Igblast stimulators, ashas been previously suggested forfreshpopula-
tions of B cells (25).h U O r V
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The relative capacity ofdendritic cells,
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anti-Ig blasts, and small B cellsto stimulate the MLR. G°-
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(A) 3 x 105 CD4+ CBA/J T cells were stimulated
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￿
in microwells with graded doses of stimulators from
CxD2 spleens. Cultures were pulsed with 1 gCi/well
°/
11°
￿
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￿
[ 3H]TdR from 85-93 h of the MLR. Proliferation
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1
￿
of T cells cultured alone was <2,000 cpm. (B) 3 x
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￿
104 CBA/J anti-CD2 T blasts (see Materials and
Methods) were restimulated in microwells with
graded doses ofallogeneic irradiated stimulators, as
3.lO' 3.101 3.105
￿
3.102 3.103 3.10'
￿
above. Control stimulators were syngeneic spleen
# stimulator cells
￿
dendritic cells. Cultures were pulsed from 18-24 h
O dendritic cells
￿
O B Celts
￿
of the secondary MLR. [3H]TdR incorporation of
° anti Ig blasts
￿
" syngeneic
￿
T blasts alone was <3,000 cpm.
dendritic cells
The Mls refers to a set of non-MHC-linked loci, which elicit strong proliferative
responses from resting T cells in mixed leukocyte cultures (24, 26). To pursue the
role of Mls, we compared the ability ofanti-Ig blasts and dendritic cells to stimulate
Mls-mismatched but MHC-matched CD4+ T cells. CBA dendritic cells stimulated
both Mls-mismatched (B6.H-2k) T cells and syngeneic (CBA) T cells at equivalent
levels, so that the dendritic cells did not appear capable of presenting Mls (Fig. 4,
topleft, right). However, CBA anti-Ig blasts were 100 times more potent in stimulating
B6.H-2k VS. CBA T cells (Fig. 4, top left, right) . Fresh B cells did stimulate an Mls
response, but at a 30-fold lower efficiency than activated B cells, consistent with a
low level contamination of fresh B cellswith in vivo-activated B cells(datanot shown).
In the absence of an Mls stimulus, dendritic cells were 10-30-fold more potent than
anti-Ig blasts at stimulating allogeneic T cells (Fig. 4, bottom). For the remainder
of our studies, except where noted, we chose to study the activity of these different
APCs in the absence of strong Mls responses because the nature and significance
of this locus remains unknown, in contrast to the MHC, which is critical in trans-
plantation and antigen presentation.
Common Features of DendritiC Cells andAnti-Ig Blasts as MLR Stimulators.
￿
One fea-
ture known to be shared by dendritic cells and LPS-induced B blasts is that stimula-
tory activity is resistant to substantial doses ofionizing irradiation (27). Stimulatory
o3 1 .101 1
# stimulator cells
Cdendritlc cells
° anti Ig blasts
-no MAb, C' only
----- 33D1, aDC+C'
- RA3-3A1,aB220+C'
FIGURE 3.
￿
Purity of dendritic cell and anti-Ig
blast stimulator populations. CxD2 spleen den-
dritic cells and anti-Ig blasts were prepared and
the cells were then split into three aliquots and
incubated on ice with 33D1 (anti-dendritic cell
mAb), RA3-3A1/6.1 (anti-B220 mAb), or con-
trol medium. Rabbit complement was added and
further incubation was continued at 37'C for 60
min. After washing, cells were resuspended to
concentrations based on precomplement deple-
tion numbers, and added in graded doses to
3 x 105 CD4+ CBA/J T cells. Percent specific
kill (relative to control medium) in the experi-
ment shown was 33D1: dendritic cells, 100%; anti-
Ig blasts, 22°70 ; RA3-3A1 : dendritic cells, 0% ;
anti-Ig blasts, 95%. Cultures were pulsed from
100-112 h of the MLR.100-
10~
7000
Syngeneic
MHC
FIGURE4.
￿
Role ofMls vs. H-2
antigens in the primary MLR
stimulated by dendritic cells vs.
anti-Ig blasts. 5 x 10 5 CD4' T
cells were stimulated with
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# stimulator cells
activity of anti-Ig blasts was comparable whether the cells were exposed to 900 or
3,000 rod of "'Cs, or mitomycin C (Fig. 5 A). In contrast, the weak stimulation
by small B cells was sensitive to 3,000 rod "'Cs (Fig. 5 A) as reported (28).
The MLR induced by either dendritic cells or anti-Ig blasts was blocked by mAb
to the appropriate class II MHC products (Fig.5 B), as expected for the CD4+ T
cell MLR. mAbsto an irrelevant MHC haplotype, orto several non-MHC antigens
onthe stimulator surface (anti-FcR, anti-leukocyte antigen) failed toblock theMLR
(data not shown).
Both dendritic cellsandanti-Igblasts induced the production ofseverallymphokines
in the primary MLR (Table I), extending our previous observations on dendritic
cells as primary MLR stimulators (20). Three factors were evaluated with specific
bioassays: IL-2, IL-4, and a BCGF that supports the growth of anti-Ig blasts but
is distinct from IL-2 and IL-4. All three activities were detected, although, on a
per cell basis, the dendritic cells were -3-10 times more active than the anti-Igblasts
in lymphokine induction (Table I). The relative levels of lymphokine production
correlated well withthe relative levels ofT cellproliferation induced by the different
stimulator cells (Fig. 5A). Small B cells were farlessactive than either anti-Ig blasts
ordendritic cells at inducing thesefactors, consistent withthe minimal Tcell prolifer-
ation stimulated by these cells in the primary MLR.
Capacity ofDiferent APC to Cluster TCells.
￿
Cellular aggregates, which are selec-
tively enriched in dendritic cells and antigen-specific T lymphocytes, are the sites
in which primary MLRs are initiated in mouse (7, 21) and man (29). We noted246
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FIGURE 5.
￿
Comparable features of anti-Ig blasts and dendritic cells as MLR stimulators. (A)
Radioresistance ofMLR stimulatory function. B6xD2 dendritic cells, anti-Ig blasts, and B cells
were prepared and added in graded doses to 3 x 105 CD4' CxD2 T cells. Before addition, the
stimulators were irradiated with 900 or 3,000 rad from a 13'Cs source, or treated with mitomycin
C (Sigma Chemical Co.) at 40 pg/ml for 30 min at 37'C. Cultures were pulsed from 72 to 90
h. In a parallel secondary restimulation of alloreactive T blasts, only the stimulation by freshly
isolated B cells was abolished by high dose ionizing radiation (data not shown). (B) mAb to I-A/
I-E blocks MLR stimulation. CxD2 spleen-derived dendritic cells, B cells, and anti-Ig blasts
were prepared and added in graded doses to 3 x 105 CD4' CBA/J T cells. 25% (vol/vol) anti-Ia
hybridoma supernatant (M5/114 ATCC TIB 120) or control medium was added at the start of
the MLR. M5/114 reacts with both I-A and I-E of the H-2`1 haplotype. Cultures were pulsed
from 85 to 93 h of the MLR. A control isotype-matched hybridoma supernatant had no effect
on MLRs by all three stimulators (data not shown).
TABLE I
Lymphokine Production in the MLR Induced by
Different Populations of Allogeneic Leukocytes
O dendritic cells
zs anti Ig blasts
O B cells
-control medium
----- onti lo
The MLR cultures are identical to those set up to measure proliferative responses in Fig 5A.
At 72 h of the ongoing primary MLR, 100 ttl was removed from each microwell and tested
for IL-2, IL-4, and BCGF.
IL-2Assay.
￿
Supernatants were tested in the CTLL proliferation assay at 20 , 70 vol/vol. The
[3H]TdR incorporation by CTLL cultured with supernatants from unstimulated T cells was
6,333 cpm . The maximum response with human rIL-2 (50 U/ml) was 142,907 cpm.
Anti-Ig Costimulation Assayfor IL-4.
￿
Supernatants were tested at 25% vol/vol in the assay .
Supernatants from unstimulated T cells induced incorporation of 2,887 cpm . The response
to anti-Ig in the absence of supernatants was 11,103 cpm. The reponse to supernatants alone,
in the absence of anti-Ig, ranged from 1,900 to 7,000 . The maximum response with murine
rIL-4 (100 U/ml) + anti-Ig was 80,878 cpm, and with murine rIL-4 alone was 7,860 cpm.
BCGFAssay.
￿
Supernatants were tested at 25% vol/vol for BCGF activity on anti-Ig pre-
activated blasts. [3H]TdR incorporation of anti-Ig blasts recultured in the absence of super-
natants was 3,850 cpm. The maximum responsewith EL-4-conditioned medium was 35,556cpm.
Stimulator
[3H]TdR uptake
IL-2
(cpm x 10 -3) at graded stimulator:responder
ratios
IL-4 BCGF
Cells Treatment 1 :1 1:3 1:10 1 :30 1 :100 1 :1 1:3 1:10 1 :30 1 :1 1 :3 1:10 1:30
DC 900 rad - 235 252 235 88 - 51 37 15 - 21 17 12
3,000 rad - 225 234 193 71 - 50 28 21 - 26 16 10
Mitomycin C - 211 213 207 140 - 39 30 20 - 20 19 12
a-Ig B 900 rad 189 205 117 34 - 31 26 19 18 14 15 9 7
3,000 rad 214 213 82 30 - 45 34 26 22 17 14 9 7
Mitomycin C 206 194 62 17 - 32 19 21 17 15 14 8 8
Sm B 900 rad 81 22 10 14 - 13 16 11 11 5 6 6 6
3,000 rad 12 10 6 5 - 15 13 15 16 4 4 5 4
Mitomycin C 62 30 10 7 - 16 13 15 16 6 7 7 8METLAY ET AL.
that anti-Ig blasts could also form clusters with allogeneic T cells in the primary
MLR, while small B cells could not form these clusters, as described previously (7,
29). We therefore designedexperimentsto test ifthe differences between theefficiency
of dendritic cells and anti-Ig blasts as stimulators for a primary MLR related to
their abilities to cluster Tcells or, alternatively, to activate the T cells once contact
was made. The stimulatordendriticcells andanti-Igblasts were labeled withafluores-
cent, lipophilic carbocyanine dye. Dye labeling, as described (21), did not interfere
with stimulatory activity or undergo transfer to the T cells, so that the number of
APC in the clusters could be enumerated on a hemocytometer. Clusters were iso-
lated at 48 h ofthe MLR. Afterenumerating total and dye-labeled cells (which was
used to calculate the number of responder Tcells in the clusters), the APC:T ag-
gregateswere returned to culture to monitorT cell proliferation. Although the clusters
were dissociated during their isolation, the aggregates quickly reformed in culture
(data not shown).
In Table II we have tabulated the results from a typical primary MLR involving
MHC but not Mls stimuli (B6.H-2k stimulating CxD2). The unseparated cultures
demonstrated a much higher MLR (30-fold when stimulator dose-response curves
were compared)with dendritic cells as compared to anti-Ig blasts (2nd line). In par-
allel macrowell cultures, anti-Ig blasts were much less efficient at clustering T cells;
20-fold fewer T cells were aggregated in the first 48 h of the MLR as compared
with comparable numbers ofdendritic cells (3rd line). In addition, a much lower
percentage ofthe added anti-Ig blasts were found in clusters with nearly all being
TABLE If
Comparison of Dendritic Cells and Anti-Ig Blasts in the
Initial Clustering of Antigen-reactive T Cells
5 x 106 or 5 x 105 CxD2 bulk T cells were cultured in 24- or 96-well flat-
bottomed plates, respectively. Specified doses of irradiated, diI-labeled, B6.H-2K
spleen dendritic cells or anti-Ig blasts were added. At 48 h, the macrowell cul-
tures (5 wells per dose of APC) were gently harvested and layered on Percoll
velocity gradients. Cluster and noncluster bands were harvested separately and
washed twice . Aliquots ofeach sample were dissociated by pipetting and count-
ed on a hemocytometer under bright field and green fluorescence optics in order
to enumerate the total and dye-labeled cell recoveries. The difference between
the two numbers was calculated, in each case, to represent the number of T cells
recovered. The ratio of dendritic cells to T cells in the cluster was 1:4; anti-Ig
blasts/T cells, 1:3. In all cases the total recovery of cells was <50%, primarily
due to losses on the velocity gradients. Based on the above calculations, equiva-
lent numbers of clustered T cells (6 x 103/well) were returned to culture. All
cultures were pulsed from 91 to 99 h.
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Dendritic cells Anti-Ig blasts
Initial APC :T cell ratio 1 :30 1 :30
Proliferation of bulk
cultures (rpm x 10 - ) 248 4.5
Percent of recovered T cells
in clusters at 48 h 10.1 0.4
Percent of recovered APC
in clusters at 48 h 58.8 2.3
Proliferation of clusters
(rpm x 10 -3) 24.9 11 .0248
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found in the noncluster fraction . In contrast, the majority of dendritic cells were
recovered in the cluster fraction (4th line) .
When equivalent numbersof clusteredT cellswere recultured, comparable levels
ofproliferation were noted (5th line). These studies suggest that anti-Ig blasts, once
they have bound to T cells, can induce a proliferative response just like dendritic
cells, but that the ability of anti-Ig blasts to form clusters is relatively weak .
Role of LFA-1 in Cluster Formation in the Dendritic andAnti-Ig Blast MLRs .
￿
In view
of the difference in efficiency with which dendritic cells and anti-Ig blasts formed
aggregates with T cells, we investigated whether the two types of cells might use
different cell-cell binding mechanisms . We evaluated the effects of anti-LFA-1 mAb,
which is known to reduce leukocyte cell-cell adhesions in several systems (30) .
In keeping with prior observations (31), dendriticT cell clustering appeared similar
in the presence or absence of anti-LFA-1 mAb over the first 24-48 h of the primary
MLR (Fig. 6, top) . At later time points, anti-LFA-1 appeared to weaken the clusters,
which began to fall apart . In contrast, mAb to LFA-1 totally blocked the clustering
of anti-Ig blasts and T cells from the onset of the primary MLR (Fig . 6, bottom) .
Other mAbs (to C3biR, FcR, common leukocyte antigen, or Thy-1) did not block
clustering with either dendritic cells or anti-Ig blasts as stimulators (data not shown) .
FIGURE 6 .
￿
Contrasting effects of anti-LEA-1 on the capacity ofdendritic cells and anti-Ig blasts
to cluster responding T cells . Micrographs ofMLRs between 5 x 10 5 CD4' B6.H-2K T cells
and 1 .5 x 105 CxD2 dendritic cells (top) or anti-Ig blasts (bottom) in the presence (right) or ab-
sence (left) of 25% (vol/vol) anti-LEA-1 hybridoma supernatant (FD441.8 ATCC TIB 213) . Cul-
tures were photographed from 96-well flat-bottomed plates at 24 h of theMLR.In addition, co-addition of 2ÁG2 anti-FcR mAb with anti-LEA-1 did not inhibit
the blocking effect of the anti-LEA-1 mAb, suggesting that the blocking effect was
not mediated by anegative signal delivered throughbindingto theanti-Ig blast FcR.
Furthermore, anti-LEA-1 caused only a minimal block ofclustering and prolifera-
tion in the secondary MLR thatwas restimulated by either dendritic cells or anti-Ig
blasts (data not shown).
When proliferative responses were monitored, anti-LEA-1 substantially, but in-
completely, reduced the dendritic cell-induced MLR. In contrast, the anti-Ig blast
MLR was totally blocked by anti-LFA-1 (Fig. 7, Aand B). Even in MLRs involving
MHC and Mls stimulation, where the anti-Ig blasts were nearly equipotent with
dendritic cells as stimulators, the anti-LFA-1 mAb still incompletely blocked den-
dritic cell stimulatory activity but completely blocked anti-Ig blast stimulatory ac-
tivity (Fig. 7A). These data suggest that LFA-1 plays acritical role in anti-Igblast-T
cell binding, but that binding and some proliferation can occur when anti-LEA-1
is added to dendritic cell-stimulated responses.
Stimulating Activity ofLPS-inducedBBlasts.
￿
We studied B cells that were activated
with LPS to see whether these blasts were similar to anti-Ig-activated B cells. In-
deed, LPS blasts also formed clusters with T cells in a primary MLR and this led
to T cell blastogenesis. The efficiency ofthis process was similar to that seen with
anti-Ig blasts. Furthermore, the formationofLPS blastT cell clusters wascompletely
inhibited by mAb to LFA-1 as was any subsequent T cell proliferation (Fig. 7 C).
Therefore, at this point in our studies, we are not aware ofany differences between
anti-Ig blasts and LPS blasts as stimulators of the MLR.
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￿
Role of LEA-1 in
dendritic cell vs. anti-Igblast-
stimulated primary MLR. (A)
CxD2 spleen dendriticcells and
anti-Ig blasts were added in
graded doses to 5 x 105 CD4'
B6.H-2KTcells. At thestartof
thereaction, 25% (vol/vol) anti-
LEA-1 hybridomasupernatant
(FD441 .8 ATCC TIB 213) or
control medium was added.
Cultures were pulsed from 88
to 96 hof the MLR. (B) B6.H-
2k spleen dendritic cells and
anti-Ig blasts were added in
graded doses to 5 x 105 CD4'
CxD2 Tcells. Anti-LEA-1 mAb
was addedas aboveandcultures
were pulsed from 73 to 88 h. (C)
B6.H-2Kspleen dendriticcells
and LPS blasts were added in
graded doses to 5 x 105 CD4'
CxD2 Tcells. Anti-LFA-1 mAb
was addedas aboveand cultures
were pulsed from 72 to 90 h.250
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Discussion
Previously, it was reported that freshly isolated B cells failed to activate resting
T cells in a primary MLR, but the same B cells effectively restimulated T lympho-
blasts that had been initially activated by dendritic cells (7, 8) . Since preactivation
ofthe T cellswith antigen permitted T-B interactions, we considered whether preac-
tivation of the B cells with anti-Ig might lead to effective T-B interactions. Prior studies
had shown that LPS-induced B blasts were more potent than small B cells as MLR
stimulators (7, 14). In this paper, we found that both dendritic cellsand anti-Ig-acti-
vated B cells expressed similar levels of class II MHC products, and that both cell
types could elicit strong proliferation and lymphokine production from allogeneic,
CD4+ resting T cells, in an antigen-dependent fashion. In addition, both stimu-
lators formed stable aggregates, or clusters, with the responding T cells that could
be isolated during the first 48 h ofthe primary MLR . However, there were marked
differences in the potency of allogeneic stimulation and apparent differences in the
mechanisms whereby dendritic cells and anti-Ig blasts bound antigen-reactive T cells.
Variability in the Potency ofAnti-Ig Blast Stimulatory Activity.
￿
Although anti-Ig blasts
could independently stimulate a primary MLR, in many strain combinations tested,
their potency as stimulators, on a per cell basis, ranged from 3- to 30-fold less than
dendritic cells. One source of this variability pertained to the distinct roles of MHC
and Mls antigens in an MLR. If only an MHC mismatch was present, dendritic
cells were 20-30-fold more potent than anti-Ig blasts, whereas if Mls was the stimula-
tory locus, anti-Ig blasts were at least 10-fold more potent than dendritic cells (Fig.
4). It was not clear whether dendritic cells carried Mls antigens at all, since the amount
of proliferation with Mls disparate combinations (B6.H-2k stimulated by CBA) was
equivalent to that observed with fully syngeneic dendritic and T cells (Fig. 4) . In
the presence of both Mls and MHC stimuli, i.e., CxD2 stimulating B6.H-2k, both
dendritic cells and anti-Ig blasts were potent stimulators ofprimary T cells (Fig. 7 A).
Further interpretation of these results is difficult due to the limited information
currently available on the nature of allogeneic MHC or Mls antigens. Recent data
on the structure of MHC molecules and their capacity to handle peptide antigens
suggest a role for more than just the MHC itself in allogeneic MHC stimulation ;
it is likely that the complete transplantation antigen includes a peptide bound to
the MHC product (32). It is possible that anti-Ig blasts and dendritic cells, while
carrying equivalent levels of the MHC determinants recognized by anti-la mAbs,
differ significantly in the array of peptides that they are presenting during the MLR .
Anti-Ig blasts increase their surface levels of la antigens by 10-fold during the 48
h of preparative culture, presumably by complexing newly synthesized class II mol-
ecules with the limited array of foreign proteins in FCS. Dendritic cells, in contrast,
have high levels of Ia antigens upon isolation, so it follows that these class II mole-
cules are assembled in situ and may be charged with the complex array of foreign
and self proteins encountered in lymphoid and nonlymphoid tissues. This hypothe-
sized difference between the source of the peptides presented on the class II mole-
cules of these two APC is one possible explanation for the observed difference in
their MLR stimulatory abilities. Still it is unlikely that B cells are totally devoid
of these complete transplantation antigens since even small, freshly isolated B cells
can restimulate alloreactive T cells in an antigen-dependent manner.
The nature of the Mls antigen(s) is even more obscure. Mls reactive T cell clonesMETLAY ET AL.
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show little MHC restriction (26), yet a limited range ofTCR Vß genes, which typi-
cally see antigen in association with MHC, seem to be used in Mls responses (33,
34). The latter has suggested that the Mls antigen is a peptide that is presented on
MHC molecules to the conventional TCR (33). Ifso, strong stimulation by anti-Ig
blasts in an Mls response could be explained ifthis locus encoded a protein/peptide
that was specifically expressed by B cells, in association with MHC molecules, and
that reacted with a large percentage of peripheral T cell receptors.
Differences in TCell Binding Mechanisms.
￿
In the absence ofa strong Mls antigen,
dendritic cellswere always more efficient MLR stimulatorsthan anti-Igblasts. This
increased efficiency was reflected in an increased capacity to find and aggregate al-
loreactive T cells. A much higher percentage ofdendritic cells formed clusters with
T cells, and per input dendritic cell, many moreTcells aggregated (Table II). Once
adendriticcell or anti-Ig blasthadclusteredwith aTcell, thenthelevel oftheprolifer-
ative response ofthe clustered Tcells was similar. This suggests that these two types
ofAPC, once bound to the T cells, can exert whatever accessory functions are re-
quired to make the T cell grow and secrete lymphokines.
In the previous section, we suggested one possible explanation for these observed
differences in clustering efficiency; dendritic cells mayhave more ofthe appropriate
alloantigens that participate in the binding of antigen-specific T cells. An alterna-
tive, or additional, possibility is that the two types ofAPC use different accessory
molecules to bind T cells. A variety ofadhesion molecules have been implicated in
leukocyte cell-cell bindingevents. One ofthese, LFA-1, does not appear to be critical
for the initial binding ofmurine dendritic cells to T cells (31). In contrast, we find
that the anti-Ig blast bindingto T cells is completely inhibited by anti-LFA-1 mAb.
There are several possible explanations for this difference in sensitivity to anti-
LFA-1. (a) The dendritic cell may initially bind T cells via a ligand that differs from
that recognized by LFA-1; (b) relative to anti-Igblasts, the dendritic cell mighthave
very high levels of a ligand for LFA-1, so that it is difficult to block function with
a mAb; and (c) a T cell subpopulation may be responding to the anti-Ig blasts, and
this subpopulation is uniquely dependent on accessory cell binding via an LFA-1
mechanism. Recently, it has been suggested that in the human system, memory T
cells aredistinguishedfromvirgin Tcells bydisplaying higher levels ofseveral mole-
cules, including LFA-1 (35). Thougha similar subpopulation has yet to be identified
in the mouse, they may be the cells that are specifically stimulated by MHC-
mismatched anti-Ig blasts. Any of the above explanations could also account for
the observed efficiency displayed by dendritic cells in binding T cells, compared with
anti-Ig blasts.
Pathways for B-T Interaction during Tdependent Antibody Responses.
￿
The capacity of
B cells to interact directly with T cells in situ is likely given the observations that
many T -dependent antibody responses are restricted to the MHC ofthe B cell, and
both MHC and TCR molecules are transmembrane glycoproteins. However, the
studies of the MLR and antibody responses in culture have indicated that either
the T cell or B cellmust first bestimulated before an MHC-restricted cell-cellinter-
action occurs.
T lymphoblasts can be restimulatedby small B cellsin an MHC-restricted fashion,
and theseblasts can bind B cells in rapid binding assays (7, 36). However, dendritic
cells are required to generate these blasts from resting precursors. It was therefore252
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proposed that one pathway for generating an antibody response would be for the
dendritic cell to induce T lymphoblasts and then the latter could interact with the
B cell (7, 11).
The data on B cells, in this and other studies, are that B lymphoblasts can initiate
a primary MLR whereas small B cells are weak stimulators. In fact, when high den-
sity B cells were isolated, we were unable to detect any primary MLR stimulatory
activity, suggesting that the weak activity of freshly isolated small B cells was due
to their contamination with lower density B blasts generated in situ. To further assess
the physiological impact of our findings, it will be important to determine if Tde-
pendent antigens can induce a B blast that is comparable to the anti-Ig and LPS
blasts that have been studied. It also will be of interest to compare B blasts and den-
dritic cells as stimulators of allogeneic T cells in vivo to further assess their capacity
to initiate cell-mediated immune responses.
Summary
Highly enriched populations of B lymphoblasts have been isolated after culture
with anti-Ig-Sepharose and compared with dendritic cells as stimulators of CD4'
T cells in the murine MLR. The two populations clearly differed in phenotype; anti-Ig
blasts were FcR', B220', 33131 -, while dendritic cells were FcR-, B220-, 33131'.
However, as MLR stimulators, they shared many common features. Both cells (a)
expressed comparable levels of class II MHC products; (b) independently stimu-
lated the primary MLR and the production of several T derived lymphokines in-
cluding IL-2 and IL-4; and (c) were comparable in stimulating freshly sensitized
T cells. However, the relative potencies of dendritic cells and anti-Ig blasts as pri-
mary MLR stimulators varied in a strain-dependent fashion. Only anti-Ig blasts
could stimulate across an Mls barrier, being at least 100 times more active in stimulating
Mls-mismatched, MHC-matched T cells, relative to syngeneic T cells. In contrast,
dendritic cells were 10-30 times more potent than anti-Ig blasts when stimulating
across an MHC barrier and were likewise more effective in binding MHC-disparate
T cells to form the clusters in which the MLR was generated. Dendritic cell-T cell
clustering was resistant to anti-LFA-1 mAb, while B blastT cell clustering was to-
tally blocked . Thus, anti-Ig B lymphoblasts and dendritic cells, two cell types which
differ markedly in phenotype, also differ in efficiency and mechanism for initiating
responses in allogeneic T cells.
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